Cargando…

Histopathological features of prostate cancer conspicuity on multiparametric MRI: protocol for a systematic review and meta-analysis

INTRODUCTION: Multiparametric MRI (mpMRI) has improved risk stratification for men with suspected prostate cancer. Indeed, mpMRI-visible tumours tend to be larger and of higher pathological grade than mpMRI-invisible tumours; however, concern remains around significant cancer that is undetected by m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Norris, Joseph M, Carmona Echeverria, Lina M, Simpson, Benjamin S, Ball, Rhys, Freeman, Alex, Kelly, Daniel, Kirkham, Alex, Whitaker, Hayley C, Emberton, Mark
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Urology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7583062/ https://www.ncbi.nlm.nih.gov/pubmed/33093035 http://dx.doi.org/10.1136/bmjopen-2020-039735

Ejemplares similares

Genetic landscape of prostate cancer conspicuity on multiparametric MRI: a protocol for a systematic review and bioinformatic analysis
por: Norris, Joseph M, et al.
Publicado: (2020)

Clinical outcomes associated with prostate cancer conspicuity on biparametric and multiparametric MRI: a protocol for a systematic review and meta-analysis of biochemical recurrence following radical prostatectomy
por: Morka, Naomi, et al.
Publicado: (2021)

Relationship of prostate cancer topography and tumour conspicuity on multiparametric magnetic resonance imaging: a protocol for a systematic review and meta-analysis
por: Satish, Pranav, et al.
Publicado: (2022)

Prostate-specific membrane antigen positron emission tomography compared to multiparametric MRI for prostate cancer diagnosis: a protocol for a systematic review and meta-analysis
por: Zhao, Yi, et al.
Publicado: (2021)

Use of artificial intelligence in the detection of primary prostate cancer in multiparametric MRI with its clinical outcomes: a protocol for a systematic review and meta-analysis
por: Thomas, Maya, et al.
Publicado: (2023)

Conspicuity of prostate cancer on multiparametric magnetic resonance imaging: A cross‐disciplinary translational hypothesis
por: Norris, Joseph M., et al.
Publicado: (2020)

Genetic Landscape of Prostate Cancer Conspicuity on Multiparametric Magnetic Resonance Imaging: A Systematic Review and Bioinformatic Analysis
por: Norris, Joseph M., et al.
Publicado: (2020)

Exploring Patient Views and Acceptance of Multiparametric Magnetic Resonance Imaging for the Investigation of Suspected Prostate Cancer (the PACT Study): A Mixed-Methods Study Protocol
por: Norris, Joseph M., et al.
Publicado: (2020)

Comparison of Multiparametric Magnetic Resonance Imaging with Prostate-Specific Membrane Antigen Positron-Emission Tomography Imaging in Primary Prostate Cancer Diagnosis: A Systematic Review and Meta-Analysis
por: Zhao, Yi, et al.
Publicado: (2022)

Comparing biparametric to multiparametric MRI in the diagnosis of clinically significant prostate cancer in biopsy-naive men (PRIME): a prospective, international, multicentre, non-inferiority within-patient, diagnostic yield trial protocol
por: Asif, Aqua, et al.
Publicado: (2023)

The Predictive Value of Prostate-Specific Antigen Density: A Retrospective Analysis of Likert 3 Multiparametric MRI of the Prostate
por: Feyisetan, Oladapo, et al.
Publicado: (2023)

Prostate cancer diagnostic pathway: Is a one-stop cognitive MRI targeted biopsy service a realistic goal in everyday practice? A pilot cohort in a tertiary referral centre in the UK
por: Bass, Edward James, et al.
Publicado: (2018)

A multicentre randomised controlled trial assessing whether MRI-targeted biopsy is non-inferior to standard transrectal ultrasound guided biopsy for the diagnosis of clinically significant prostate cancer in men without prior biopsy: a study protocol
por: Kasivisvanathan, Veeru, et al.
Publicado: (2017)

Diagnosis and Monitoring of Prostatic Lesions: A Comparison of Three Modalities: Multiparametric MRI, Fusion MRI/Transrectal Ultrasound (TRUS), and Traditional TRUS
por: Birs, Antoinette, et al.
Publicado: (2016)

The accuracy of multiparametric MRI in men with negative biopsy and elevated PSA level—Can it rule out clinically significant prostate cancer?
por: Abd-Alazeez, Mohamed, et al.
Publicado: (2014)

Regional Histopathology and Prostate MRI Positivity: A Secondary Analysis of the PROMIS Trial
por: Stavrinides, Vasilis, et al.
Publicado: (2023)

PEDAL protocol: a prospective single-arm paired comparison of multiparametric MRI and 18F-DCPFyl PSMA PET/CT to diagnose prostate cancer
por: Tran, Vy, et al.
Publicado: (2022)

Image-directed, tissue-preserving focal therapy of prostate cancer: a feasibility study of a novel deformable magnetic resonance-ultrasound (MR-US) registration system
por: Dickinson, Louise, et al.
Publicado: (2013)

What Type of Prostate Cancer Is Systematically Overlooked by Multiparametric Magnetic Resonance Imaging? An Analysis from the PROMIS Cohort
por: Norris, Joseph M., et al.
Publicado: (2020)

Detailing sexual outcomes after treatment of localised prostate cancer with focal therapy using various energy sources: protocol for a mixed-methods study
por: Fiard, Gaelle, et al.
Publicado: (2020)

Which Prostate Cancers are Undetected by Multiparametric Magnetic Resonance Imaging in Men with Previous Prostate Biopsy? An Analysis from the PICTURE Study
por: Norris, Joseph M., et al.
Publicado: (2021)

“Textural analysis of multiparametric MRI detects transition zone prostate cancer”
por: Sidhu, Harbir S., et al.
Publicado: (2016)

Clinical and Histopathological Characteristics of Prostate Cancer Patients Taken to Palliative Transurethral Prostate Resection
por: Rojas-Manrique, Juan P, et al.
Publicado: (2019)

ReIMAGINE Prostate Cancer Screening Study: protocol for a single-centre feasibility study inviting men for prostate cancer screening using MRI
por: Marsden, Teresa, et al.
Publicado: (2021)

Evaluating variation in use of definitive therapy and risk-adjusted prostate cancer mortality in England and the USA
por: Sachdeva, Ashwin, et al.
Publicado: (2015)

Evaluation of PSA and PSA Density in a Multiparametric Magnetic Resonance Imaging-Directed Diagnostic Pathway for Suspected Prostate Cancer: The INNOVATE Trial
por: Pye, Hayley, et al.
Publicado: (2021)

Clinical applications of multiparametric MRI within the prostate cancer diagnostic pathway()
por: Dickinson, Louise, et al.
Publicado: (2013)

MRI findings in men on active surveillance for prostate cancer: does dutasteride make MRI visible lesions less conspicuous? Results from a placebo-controlled, randomised clinical trial
por: Giganti, Francesco, et al.
Publicado: (2017)

Five-year Outcomes of Magnetic Resonance Imaging–based Active Surveillance for Prostate Cancer: A Large Cohort Study [Image: see text] ()
por: Stavrinides, Vasilis, et al.
Publicado: (2020)

Prostate MRI versus PSA screening for prostate cancer detection (the MVP Study): a randomised clinical trial
por: Nam, Robert, et al.
Publicado: (2022)

Does a novel diagnostic pathway including blood-based risk prediction and MRI-targeted biopsies outperform prostate cancer screening using prostate-specific antigen and systematic prostate biopsies? - protocol of the randomised study STHLM3MRI
por: Nordström, Tobias, et al.
Publicado: (2019)

A Comparative Study: Has MRI-guided Fusion Prostate Biopsy Changed the Prostate-specific Antigen Gray-zone Range?
por: Sönmez, Gökhan, et al.
Publicado: (2019)

False Positive Multiparametric Magnetic Resonance Imaging Phenotypes in the Biopsy-naïve Prostate: Are They Distinct from Significant Cancer-associated Lesions? Lessons from PROMIS [Image: see text] ()
por: Stavrinides, Vasilis, et al.
Publicado: (2021)

A Single-center Experience: Does MRI-guided Target Prostate Biopsy Meet Expectations?
por: Demirtaş, Türev, et al.
Publicado: (2019)

Mapping PSA density to outcome of MRI-based active surveillance for prostate cancer through joint longitudinal-survival models
por: Stavrinides, Vasilis, et al.
Publicado: (2021)

Four‐year outcomes from a multiparametric magnetic resonance imaging (MRI)‐based active surveillance programme: PSA dynamics and serial MRI scans allow omission of protocol biopsies
por: Gallagher, Kevin Michael, et al.
Publicado: (2018)

NeuroSAFE robot-assisted laparoscopic prostatectomy versus standard robot-assisted laparoscopic prostatectomy for men with localised prostate cancer (NeuroSAFE PROOF): protocol for a randomised controlled feasibility study
por: Dinneen, Eoin, et al.
Publicado: (2019)

Primary Small Lymphocytic Lymphoma of the Renal Capsule: A Histopathological Case Report
por: Popov, Hristo, et al.
Publicado: (2019)

How Does the COVID-19 Pandemic Influence Histopathological Outcomes for Urologic Cancers?
por: Kalemci, Serdar, et al.
Publicado: (2022)

Editorial Comment: Radical prostatectomy without prior biopsy following multiparametric magnetic resonance imaging and prostate-specific membrane antigen positron emission tomography
por: Teles, Saulo Borborema, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_q3n1el0ni6qhciu60vrhjjglrt